Small Pharma Inc (DMT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
(Values in thousands)
| 05-2023 | 02-2023 | 11-2022 | 08-2022 | 05-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 86 | 31 | 6 | 6 | 6 |
| Accounts receivable | 192 | 63 | -88 | -109 | 484 |
| Other Working Capital | -328 | -2,391 | 1,525 | 855 | -645 |
| Other Operating Activity | -5,708 | -2,254 | -6,800 | -6,752 | -6,148 |
| Operating Cash Flow | $-5,759 | $-4,550 | $-5,358 | $-5,999 | $-6,304 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -5 | -2 | 0 | -11 |
| Other Investing Activity | 0 | -11 | 0 | 2,500 | 0 |
| Investing Cash Flow | $0 | $-16 | $-2 | $2,500 | $-11 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -83 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | 0 | -281 | N/A | N/A |
| Other Financing Activity | 0 | -13 | 0 | -157 | 15 |
| Financing Cash Flow | $-83 | $-13 | $-281 | $-157 | $15 |
| Exchange Rate Effect | 457 | 372 | 1,240 | -1,197 | -2,357 |
| Beginning Cash Position | 18,537 | 22,744 | 27,145 | 31,999 | 40,656 |
| End Cash Position | 13,152 | 18,537 | 22,744 | 27,145 | 31,999 |
| Net Cash Flow | $-5,842 | $-4,580 | $-5,641 | $-3,656 | $-6,299 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,759 | -4,550 | -5,358 | -5,999 | -6,304 |
| Capital Expenditure | N/A | -16 | -2 | 0 | -11 |
| Free Cash Flow | -5,759 | -4,566 | -5,360 | -5,999 | -6,314 |